Clinical Trial Update: Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

View source ↗

Summary

A completed clinical trial evaluated the Signa Excite 3.0 T MRI system for detecting and characterizing liver lesions in liver cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer | Status: COMPLETED